LEADER 01362nam  2200409   450 
001 9910707365003321
005 20160715101331.0
035   $a(CKB)5470000002463867
035   $a(OCoLC)953619496
035   $a(OCoLC)995470000002463867
035   $a(EXLCZ)995470000002463867
100   $a20160715d1995      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMedicaid drug use review programs $elessons learned by states
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d1995.
215   $a1 online resource (v, 26, A-3 pages) $cillustrations
300   $aTitle from title screen (viewed July 13, 2016).
300   $a"May 1995."
300   $a"OEI-01-92-00800."
320   $aIncludes bibliographical references (pages A-1-A-3).
517   $aMedicaid drug use review programs 
606   $aMedicaid beneficiaries
606   $aDrug utilization$zUnited States
606   $aTherapeutics$zUnited States$xEvaluation
615  0$aMedicaid beneficiaries.
615  0$aDrug utilization
615  0$aTherapeutics$xEvaluation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707365003321
996   $aMedicaid drug use review programs$93531276
997   $aUNINA